AbstractLong-term stable mixed chimerism (MC) is a rare phenomenon after hematopoietic stem cell transplantation (HSCT) characterized by 5% to 95% residual recipient hematopoietic cells. The underlying mechanisms of MC are largely unknown. In this study we compared full donor chimerism with long-lasting stable MC for a median of 9.5 years (range, 5 to 16.5) post-HSCT in patients with nonmalignant diseases. Several factors significantly associated with the likelihood of stable MC development were identified by univariate analysis, eg, younger donor age, sibling donor, and conditioning regimen. Despite a limited patient cohort, our multivariate analysis could confirm that a sibling donor was associated with stable MC development. Furthermore,...
AbstractHematopoietic stem cell transplantation is the curative option for patients with myelodyspla...
Hematopoietic stem cell transplantation is the curative option for patients with myelodysplastic syn...
AbstractA multicenter investigation of allogeneic bone marrow transplantation for children with sick...
AbstractLong-term stable mixed chimerism (MC) is a rare phenomenon after hematopoietic stem cell tra...
Long-term stable mixed chimerism is a rare and poorly understood phenomenon post hematopoietic stem ...
The objective of this study is to analyze the evolution of chimerism of all patients transplanted fo...
Using red cell phenotyping (RCP) and/or cytogenetics (CYT) we identified 19 patients with persisting...
The objective of this study is to analyze the evolution of chimerism of all patients transplanted fo...
Item does not contain fulltextUsing red cell phenotyping (RCP) and/or cytogenetics (CYT) we identifi...
AbstractHematopoietic stem cell transplantation is the curative option for patients with myelodyspla...
AbstractDonor chimerism after allogeneic stem cell transplantation (allo-SCT) is commonly used to pr...
AbstractA multicenter investigation of allogeneic bone marrow transplantation for children with sick...
Mixed donor chimerism after hematopoietic cell transplantation for sickle cell disease (SCD) can res...
Mixed donor chimerism after hematopoietic cell transplantation for sickle cell disease (SCD) can res...
Mixed donor chimerism after hematopoietic cell transplantation for sickle cell disease (SCD) can res...
AbstractHematopoietic stem cell transplantation is the curative option for patients with myelodyspla...
Hematopoietic stem cell transplantation is the curative option for patients with myelodysplastic syn...
AbstractA multicenter investigation of allogeneic bone marrow transplantation for children with sick...
AbstractLong-term stable mixed chimerism (MC) is a rare phenomenon after hematopoietic stem cell tra...
Long-term stable mixed chimerism is a rare and poorly understood phenomenon post hematopoietic stem ...
The objective of this study is to analyze the evolution of chimerism of all patients transplanted fo...
Using red cell phenotyping (RCP) and/or cytogenetics (CYT) we identified 19 patients with persisting...
The objective of this study is to analyze the evolution of chimerism of all patients transplanted fo...
Item does not contain fulltextUsing red cell phenotyping (RCP) and/or cytogenetics (CYT) we identifi...
AbstractHematopoietic stem cell transplantation is the curative option for patients with myelodyspla...
AbstractDonor chimerism after allogeneic stem cell transplantation (allo-SCT) is commonly used to pr...
AbstractA multicenter investigation of allogeneic bone marrow transplantation for children with sick...
Mixed donor chimerism after hematopoietic cell transplantation for sickle cell disease (SCD) can res...
Mixed donor chimerism after hematopoietic cell transplantation for sickle cell disease (SCD) can res...
Mixed donor chimerism after hematopoietic cell transplantation for sickle cell disease (SCD) can res...
AbstractHematopoietic stem cell transplantation is the curative option for patients with myelodyspla...
Hematopoietic stem cell transplantation is the curative option for patients with myelodysplastic syn...
AbstractA multicenter investigation of allogeneic bone marrow transplantation for children with sick...